source name	characteristics[organism]	characteristics[organism part]	characteristics[cell line]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[cell type]	characteristics[developmental stage]	Material Type	assay name	Technology Type	comment[file uri]	comment[fraction identifier]	comment[label]	comment[cleavage agent details]	comment[fractionation method]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters].2	comment[modification parameters].3	comment[modification parameters].4	comment[modification parameters].5	comment[modification parameters].6	comment[dissociation method]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[data file]	factor value[cell line]
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 129	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_1.raw	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_1.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 130	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_2.raw	2	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_2.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 131	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_3.raw	3	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_3.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 132	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_4.raw	4	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_4.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 133	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_5.raw	5	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_5.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 134	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_6.raw	6	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_6.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 135	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_7.raw	7	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_7.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 136	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_8.raw	8	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_8.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 137	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_9.raw	9	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_9.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 138	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_10.raw	10	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_10.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 139	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_11.raw	11	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_11.raw	HeLa
Sample 4	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 140	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_12.raw	12	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_12.raw	HeLa
